{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T19:44:07Z","timestamp":1781207047255,"version":"3.54.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Kidney Cancer Research Network of Canada"},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"name":"BMS"},{"DOI":"10.13039\/501100014382","name":"Ipsen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014382","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Movember Canada"},{"DOI":"10.13039\/501100000109","name":"Prostate Cancer Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013796","name":"Canadian Urological Association Scholarship Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013796","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000196","name":"Canada Foundation for Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009326","name":"Cancer Research Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012317","name":"Astellas Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012317","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.clon.2019.07.010","type":"journal-article","created":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T08:09:50Z","timestamp":1564646990000},"page":"e10-e15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Application of Hereditary Renal Cell Carcinoma Risk Criteria to a Large Prospective Database"],"prefix":"10.1016","volume":"32","author":[{"given":"I.","family":"Kushnir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Kirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Mallick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.E.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.H.","family":"Breau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-B.","family":"Lattouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.D.","family":"Violette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.E.","family":"Pautler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Care","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.S.","family":"Jewett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Tanguay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.Y.C.","family":"Heng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.S.","family":"Basappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"So","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Pouliot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.M.","family":"Reaume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2019.07.010_bib1","unstructured":"Canadian Cancer Society. Available at: http:\/\/www.cancer.ca\/en\/cancer-information\/cancer-type\/kidney\/statistics\/?region=on. Accessed 1 June 2019."},{"key":"10.1016\/j.clon.2019.07.010_bib2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/nrurol.2010.46","article-title":"Epidemiology and risk factors for kidney cancer","volume":"7","author":"Chow","year":"2010","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.clon.2019.07.010_bib3","first-page":"1309","article-title":"Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma","volume":"183","author":"Leibovich","year":"2010","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.clon.2019.07.010_bib4","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1200\/JCO.2013.50.8192","article-title":"Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management","volume":"32","author":"Shuch","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2019.07.010_bib5","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","article-title":"von Hippel-Lindau disease","volume":"361","author":"Lonser","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.clon.2019.07.010_bib6","doi-asserted-by":"crossref","first-page":"E214","DOI":"10.5489\/cuaj.3798","article-title":"Structured assessment and followup for patients with hereditary kidney tumour syndromes","volume":"10","author":"Lattouf","year":"2016","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.clon.2019.07.010_bib7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.5489\/cuaj.1496","article-title":"Canadian guideline on genetic screening for hereditary renal cell cancers","volume":"7","author":"Reaume","year":"2013","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.clon.2019.07.010_bib8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ucl.2016.12.002","article-title":"Hereditary kidney cancer syndromes and surgical management of the small renal mass","volume":"44","author":"Nguyen","year":"2017","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.clon.2019.07.010_bib9","first-page":"1475","article-title":"Renal cancer in families with hereditary renal cancer: prospective analysis of a tumor size threshold for renal parenchymal sparing surgery","volume":"161","author":"Walther","year":"1999","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.clon.2019.07.010_bib10","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/gim.2014.147","article-title":"A\u00a0practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment","volume":"17","author":"Hampel","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.clon.2019.07.010_bib11","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s10897-016-0020-4","article-title":"Prevalence and characteristics of patients with suspected inherited renal cell cancer: application of the ACMG\/NSGC genetic referral guidelines to patient cohorts","volume":"26","author":"Truong","year":"2017","journal-title":"J\u00a0Genet Couns"},{"key":"10.1016\/j.clon.2019.07.010_bib12","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/cge.12647","article-title":"Genetic testing for BRCA1 and BRCA2 in the Province of Ontario","volume":"89","author":"Finch","year":"2016","journal-title":"Clin Genet"},{"key":"10.1016\/j.clon.2019.07.010_bib13","doi-asserted-by":"crossref","first-page":"E832","DOI":"10.5489\/cuaj.2415","article-title":"Knowledge of genetic testing for hereditary kidney cancer in Canada is lacking: the results of the Canadian national hereditary kidney cancer needs assessment survey","volume":"8","author":"Violette","year":"2014","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.clon.2019.07.010_bib14","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1001\/jamaoncol.2018.1986","article-title":"Prevalence of germline mutations in cancer susceptibility genes in patients with advanced renal cell carcinoma","volume":"4","author":"Carlo","year":"2018","journal-title":"JAMA Oncol"},{"issue":"11","key":"10.1016\/j.clon.2019.07.010_bib15","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1200\/JCO.2015.63.3594","article-title":"Increased risk for other cancers in addition to breast cancer for CHEK2*1100delC heterozygotes estimated from the Copenhagen General Population Study","volume":"34","author":"N\u00e4slund-Koch","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.clon.2019.07.010_bib16","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1086\/426403","article-title":"CHEK2 is a multiorgan cancer susceptibility gene","volume":"75","author":"Cybulski","year":"2004","journal-title":"Am J Hum Genet"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655519302900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655519302900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:46:50Z","timestamp":1760543210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655519302900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0936655519302900"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2019.07.010","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of Hereditary Renal Cell Carcinoma Risk Criteria to a Large Prospective Database","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2019.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}